Robert E. Reiter, MD
Co-Founder of ImaginAb, Consultant
Dr. Reiter is a Professor of Urology and Molecular Biology and Director of the Prostate Cancer Treatment and Research Program at the David Geffen School of Medicine at UCLA. He is currently the Principal Investigator of UCLA’s SPORE (Specialized Program in Research Excellence) program, a 12 million dollar research grant from the National Cancer Institute to develop new diagnostic and treatment options for men with prostate cancer. As co-developer of ImaginAb’s technology and Chief Medical Advisor, Dr. Reiter helps ensure high clinical impact and relevance by guiding the validation studies for ImaginAb’s clinical imaging pipeline. Dr. Reiter is a prominent figure …
Brian Abeysekera, PhD
Dr. Brian Abeysekera, has more than 25 years of experience in radioisotope and radiopharmaceutical development, including production, radiochemistry, quality control, quality assurance and regulatory affairs activities in the United States and Canada. He is President of PharmaSPECT Inc, a company that provides cGMP and Manufacturing, Quality and Regulatory expertise to Positron Emission Tomography (PET) and Single Photon Emission Computed Tomography (SPECT) radiopharmaceutical manufacturers. He previously served as Vice President, Manufacturing, Molecular Insight Pharmaceuticals …
Consultant, Global IP Asset Management
Thomas is a US/Canadian intellectual property (IP) and transaction attorney with 22+ years’ experience in Global IP Asset Management. He provides worldwide strategic advice for IP portfolio assets to achieve licensing, M&A and commercialization objectives. From 2005-2016, Thomas was a member of the legal/IP department at Novartis (Cambridge, MA and Basel, Switzerland).